Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Event
Ramallah, Palestine
This master-class will be held alongside 15th Pan Arab Congress of Dermatology and Venereology, jointly with the 4th International Palestinian Congress, in Ramallah (Palestine) on 8-10 November 2016. The Congress Chairman is Dr. Riad Mashal. A panel of distinguished speakers will deliver 45 min. lectures on:
- Prof. Torello Lotti - Vitiligo: what's new and what's true in 2016.
- Prof. Davinder Parsad - The selection of the best surgical procedures in vitiligo.
- Prof. Medhat Abdelmalek - Pseudocatalase treatment of vitiligo.
- Prof. Yan Valle - Vitiligo: tools and resources for researchers, clinicians and patients.
followed by Q&A session.
Participation is free. Coffee and snacks will be provided.
FAQOther Questions
- PTSD in Vitiligo?
Living with vitiligo often involves dealing with more than just skin changes. Many people with vitiligo face discrimination, social stigma, and isolation, which can lead to lowe...
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
- Will it spread?
Vitiligo's progression and response to treatment can vary significantly among individuals, making it a particularly unpredictable skin condition. Based on the VALIANT study from...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.